diabetestalk.net

Diabetes Drug Class Action Lawsuit

Texas Diabetes Drug Class Action Lawyer

Texas Diabetes Drug Class Action Lawyer

If you took a diabetes drug and developed thyroid cancer, bladder cancer, ketoacidosis, or another serious injury, you may be eligible for compensation by filing a lawsuit. Need Texas Diabetes Drug Class Action Lawyer? Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged. If you or a loved one was injured by a diabetes drug, you should contact our lawyers immediately. You may be entitled to compensation by filing a lawsuit in Texas. Actos (pioglitazone) is a type-2 diabetes drug that has been associated with a potential risk of bladder cancer. Although the drug now carries a Black Box warning about the risk of bladder cancer, many people were injured before these warnings were added to the label. The manufacturer of Actos, Takeda Pharmaceuticals, is now facing more than 1,000 Actos lawsuits filed in a federal Multi-District Litigation (MDL). SGLT2 Inhibitor Diabetes Drugs Linked to Ketoacidosis The FDA recommends that patients on the following medications should be aware of the risk of ketoacidosis and seek emergency medical attention for symptoms like difficulty breathing, nausea, vomiting, abdominal pain, confusion, and unusual fatigue or sleepiness: A class action lawsuit is a special type of litigation in which many people with similar claims consolidate their claims into one lawsuit. It makes sense when a lot of people have a relatively minor injury (for example, buying a TV with false advertisements about its screen resolution). Why Our Law Firm is Filing Individual Lawsuits Instead of a Diabetes Drug Class Action The problem with a class action lawsuit is that plaintiffs might have to split the award, accept a low-ball settlement, high attorneys fees, or compensation that doesnt cover their m Continue reading >>

Diabetes Drug Class Action Lawsuit | Diabetes 365

Diabetes Drug Class Action Lawsuit | Diabetes 365

Disclaimer: The content of this article should not be taken as legal advice and should only be used as a resource to provide information about diabetes drug class action lawsuits. You should always seek the services of a lawyer specializing in class action cases to give you a more in-depth view of this matter. Your father has diabetes . You and your family members have been providing sufficient funds for your father to ensure that he takes his medication on time and that hes able to meet his doctor appointments on time. For the longest time, everything has been going relatively well. And lately, your family has decided to acquire new medicines for your father for diabetes, as recommended by some of your friends who also have diabetes. During the first few weeks of using the new medicines, everything turned out okay. Your father was doing well and was still able to do activities that he enjoys. However, after a few months of using these more affordable medicines from the same supplier, youve noticed that your father has been coughing too much and gradually becoming weak. You asked some of your friends if they too have had the same experiences in using the medicine, and to your surprise, they did. And they have been experiencing the same side effects as your father, and some even worse. Because of this, you and your friends who have been using the medicine decided to file a diabetes drug class action lawsuit. One example of a lawsuit against pharmaceutical companies is one involving the Invokana drug, that was prescribed to millions of people with Diabetes. Thousands of claims have been filed against Johnson & Johnson and Janssen Pharmaceuticals by individuals who have suffered injuries as a result of taking Invokana. The lawsuits are presently combined before a federal Continue reading >>

Invokana Side Effects Lawyer: Diabetes Drug Lawsuit

Invokana Side Effects Lawyer: Diabetes Drug Lawsuit

Invokana has also been linked to decreased bone density and fractures that can occur from simply tripping or falling from standing height. The FDA updated the Warning and Precaution label to include that that bone fractures occur more frequently in patients using an SGLT2 inhibitor like Invokana and that they can occur after as little as 12 weeks after beginning treatment with Invokana. The FDA also required new safety information to be added to the Adverse Reaction section of the medication label warning that Invokana causes loss of bone mineral density at the lower spine and hip. This information was added in September 2015 after the results of an FDA required clinical trial showed Invokana caused greater bone loss than placebo. Invokana is also currently under investigation for a potential link to increased amputations. This investigation stems from the results of an ongoing Canagliflozin Cardiovascular Assessment Study (CANVAS) clinical trial that should be completed in 2017. The study has noted higher rates of leg, toe and foot amputations on patients taking Invokana. Per the FDA, amputations are twice as high in Invokana users than non-users. Call Now For a Free & Confidential Case Evaluation 888-992-8423 Our attorneys are fierce advocates for people harmed by dangerous drugs that offer no real benefit over similar drugs without potentially fatal side effects. If you or a family member has suffered a serious side-effect from Invokana or another SGLT2 inhibitor, you have rights under the law. We defend those rights and help you seek maximum compensation for your injuries. Texas native Attorney Adam Pulaski has spent decades fighting for the rights of persons harmed by the negligence of others. Representing clients in all 50 states, Adam uses his experience and kno Continue reading >>

Invokana Lawsuit

Invokana Lawsuit

Diabetes medications like Invokana (canagliflozin) have been linked to ketoacidosis and kidney injuries. Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a group of drugs FDA-approved to treat low blood sugar in adults with Type 2 diabetes. The FDA has warned, however, that SGLT2 inhibitors like Invokana can lead to a condition known as diabetic ketoacidosis (DKA), characterized by excessive acid levels in the blood. The FDA has also warned about bone breaks and kidney injuries associated with SGLT2 inhibitors. A number of manufacturers—including Johnson & Johnson, which makes Invokana—sell diabetic medications that are associated with harmful side effects. Hundreds of lawsuits currently await trial against Invokana in federal and state courts. Plaintiffs argue that Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) misrepresented the risks of the medication and failed to warn patients about Invokana’s side effects. If you suffered an injury caused by Invokana or a similar SGLT2 inhibitor, you may be entitled to compensation. Contact us today for a free legal consultation. Serious Invokana Side Effects Invokana and similar drugs have strong links to ketoacidosis. There is also evidence that the drugs can cause impaired kidney function, heart problems, bone breaks, and other health complications. Ketoacidosis Symptoms of ketoacidosis, as noted by the American Diabetes Association, include: Trouble breathing Nausea Vomiting Abdominal pain Confusion or difficulty concentrating Unusual fatigue or sleepiness Dry or flushed skin Kidney Injuries Adverse event data has also pointed to possible impaired kidney function caused by Invokana and similar drugs. Adverse renal functions associated with these drugs include: Kidney failure Kidney impairment Dehydratio Continue reading >>

Type 2 Diabetes Drug Lawsuit – Risk Of Diabetic Ketoacidosis

Type 2 Diabetes Drug Lawsuit – Risk Of Diabetic Ketoacidosis

As more and more Type 2 diabetes drugs hit the market, managing the disease becomes less of a hassle for many. Unfortunately in some cases, the risks of taking these medications outweigh the reward and users are finding the serious side effects they experience are just not worth it. Though side effects can occur with any of the diabetes drugs available – or any drug for that matter – some of the most serious issues are related to sodium-glucose co-transporter (SGLT2) inhibitors, which are the newest class of type 2 diabetes medications. These drugs have been available for approximately two years and already, users have suffered numerous adverse reactions, many of which were life-threatening. There are several SGLT2 medications on the market. The first approved was Invokana, which made it to market despite five of the 15 members of the advistory panel voting against approval because of the drug’s potential link to heart attack. Farxiga, which had its original application denied by the FDA due to concerns of the drug’s effect on the liver, was later approved in the winter of 2014. Members of the FDA approval panels were not the only ones concerned about SGLT2 inhibitors. The advocacy group Public Citizen voiced its concern for the medications, stating they do not think the information available is adequate and that there is evidence the drugs cause harm. They have SGLT2 inhibitors on their list of “do not use” medications on their website. SGLT2 Inhibitors Cause Minor and Severe Side Effects Health officials have taken notice and following a number of adverse reactions to SGLT2 inhibitors, the FDA issued a warning to health care professionals in the spring of 2015 concerning a link to diabetic ketoacidosis. The agency had received 20 reports, but hundreds more Continue reading >>

The Invokana Lawsuit - Amputations, Ketoacidosis & Kidney Injuries

The Invokana Lawsuit - Amputations, Ketoacidosis & Kidney Injuries

The Invokana lawsuits claim the manufacturers of Invokana failed to warn patients and physicians of the increased risks of amputations, kidney failure and ketoacidosis. Our law firm is accepting clients who took Invokana and suffered any of the above injuries. We have been handling claims against pharmaceutical companies since 1955, and we are listed in Best Lawyers in America and The National Trial Lawyers Hall of Fame. Why are Invokana Lawsuits Being Filed Thousands of claims have been filed against Johnson & Johnson and Janssen Pharmaceuticals by individuals who have suffered injuries as a result of taking Invokana. The lawsuits are presently combined before a federal judge in New Jersey where all of the national discovery and evidence gathering is taking place. Invokana linked to amputations, kidney damage and ketoacidosis. Yet, the manufacturers failed to properly warn. In the court filings, lawyers argue the following: Invokana is defective and unreasonably dangerous. Johnson & Johnson was negligent in the manufacturing of the drug. The company failed to properly test the medication, and failed to warn of the increased risks of amputations, kidney failure and ketoacidosis. Johnson & Johnson concealed evidence of the dangers from the government and the public, and misrepresented the safety of the drug in its marketing material. The most serious potential side effects and risks caused by Invokana are amputations, kidney damage and ketoacidosis. Clinical trials have found that patients taking Invokana are twice as likely to suffer a leg or foot amputation as those taking a placebo. Toe amputations and those in the middle of the foot are most common. Individuals taking Invokana should be especially careful to look for signs of increased tenderness, sores, ulcers, and Continue reading >>

Diabetes Drug Class Action Lawsuit

Diabetes Drug Class Action Lawsuit

Dozens of new diabetes medications have been linked to severe, life-threatening side effects like pancreatic cancer, thyroid cancer, and ketoacidosis. Drug-makers are already facing hundreds of lawsuits for selling unsafe medications and failing to warn about side effects. The Schmidt Firm, PLLC is currently accepting diabetes drug induced injury cases in all 50 states. If you or somebody you know was diagnosed with cancer or ketoacidosis, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753. There is new evidence that diabetes drugs in the incretin mimetic class may increase a patients risk of pancreatic cancer . These drugs work by increasing hormones that cause the pancreas to produce more insulin. The FDA has been investigating pancreatic side effects since 2007. The first incretin mimetic on the market, Byetta, has also been linked to a risk of thyroid cancer . In October 2009, the FDA asked drug-makers to explore a potential signal of a serious risk of thyroid cancer. The agency was concerned about studies in rodents suggesting that incretin therapy could lead to thyroid C-cell carcinoma (medullary thyroid cancer). In Febuary 2015, the FDA announced that it would investigate the risk of heart failure from Onglyza. The agency was concerned about a 27% increased risk of hospitalization for heart failure, and a possible increased risk of all-cause mortality (death) that was seen in the SAVOR clinical trial . SGLT2 Inhibitor Diabetes Drugs Linked to Ketoacidosis In December 2015, the FDA reported that 73 cases of ketoacidosis had been linked to SGLT2 inhibitors between March 2013 and May 2015. All of the victims were hospi Continue reading >>

Lipitor Lawsuit: Women's Diabetes Class Action Lawyers

Lipitor Lawsuit: Women's Diabetes Class Action Lawyers

To review a potential case for yourself, a friend or family member, Request a free consultation and claim evaluation . Lipitor (atorvastatin) was introduced in 1996 by Warner-Lambert Company, which was subsequently acquired by Pfizer. Individuals diagnosed with diabetes after Lipitor use may be entitled to financial compensation through a product liability lawsuit. Amid agressive marketing and promotion, the cholesterol drug became one of the top selling brand name drugs in the world, generating more than $125 billion in sales before generic Lipitor became available in 2011. Lipitor is a member of a class of drugs known as statins, which work by preventing the liver from creating an enzyme that helps the body produce cholesterol. This helps the body reduce the levels of low-density lipoprotein (LDL) cholesterol, often referred to as bad cholesterol. Statins have been linked to a number of serious health problems and side effects, including muscle injury, kidney problems, and diabetes. In 2012, the FDA forced label changes for Lipitor and other statins to add information to the Warnings and Precautions section about the potential link to an increased risk of diabetes. However, the Lipitor warnings added by Pfizer remain incomplete and inadequate, failing to properly warn users or the medical community about the risk of diabetes or the importance of monitoring blood glucose levels. As a result, thousands of women may have developed diabetes from Lipitor that could have been avoided if more accurate information had been provided about the risk. Complaints have been filed in courts throughout the country on behalf of individuals diagnosed with diabetes from Lipitor, and additional claims are being reviewed as a result of Pfizers decision to place their desire for profits b Continue reading >>

Invokana Lawsuit: Amputation & Ketoacidosis Legal Claims

Invokana Lawsuit: Amputation & Ketoacidosis Legal Claims

People who say they suffered serious injuries after taking Invokana and other SGLT2 inhibitor diabetes drugs are suing the manufacturers in the U.S. and Canada seeking compensation for what happened to them. The lawsuits are the subject of two federal Multidistrict Litigations, and trials have not yet begun. SGLT2 drug lawsuits are in their early stages and have not yet proceeded to trial or been part of any large settlements. But the cases involving about 800 plaintiffs who say the drugs caused injuries are proceeding on several fronts: The U.S. Judicial Panel on Multidistrict Litigation ordered Invokana cases consolidated in multidistrict litigation (MDL) No. 2750 in New Jersey before Judge Brian R. Martinotti. As of Dec. 18, 2017, over 990 cases were involved in the Invokana MDL. Clarkson S. Fisher Federal Courthouse, site of the Invokana New Jersey MDL According to Johnson & Johnson, there are also federal lawsuits over Invokana pending in federal court in California and Missouri. There are also cases in state courts in Pennsylvania, California and New Jersey. U.S. District Judge Lorna G. Schofield is overseeing a Farxiga MDL in the Southern District of New York. As of Dec. 18, 2017, there were 55 cases pending in the Farxiga MDL. Bellwether trials involve cases selected by the parties to go to trial first in MDLs and other mass torts. These initial trials are expected to help the parties get an idea how the remaining cases may play out, providing useful information to guide potential settlement negotiations. Bellwether trials help parties get an idea how the remaining cases may play out. For example, if the bellwether trials end with large verdicts, that suggests other cases may warrant large settlements. If, on the other hand, the drugmaker prevails in the initia Continue reading >>

Class Actions: Dangerous Drugs And Medical Devices List|practice Areas

Class Actions: Dangerous Drugs And Medical Devices List|practice Areas

Accutane, also known as isotretinoin, is an oral medication used to treat acne, and works by shrinking the oil glands within the skin. Originally approved by the Food and Drug Administration (FDA) in 1982, Accutane was taken off the market in July 2009. [] Read more A recent investigation found hundreds of deaths linked the Rheumatoid arthritis drug Actemra, as research points to an increased risk of heart attacks, strokes, heart failure, and other conditions for those taking it. Despite the reports, neither Actemras manufacturer nor the U.S. Food and Drug Administration have ordered changes to the drugs warning label, putting countless Americans at risk of serious side effects, including death. [] Read more Classified as a thiazolidinedione, Actos is from the same family of drugs as Avandia another controversial diabetic medication due to its negative side effects. In fact, following an FDA study, a safety alert was released on Aug 14th, 2007 warning that pioglitazone (the generic name of Actos) may cause or increase the risk of heart failure in certain patient populations. [] Read more Ambien, also known as zolpidem, is prescribed to people suffering from insomnia. Some users have reportedly been injured or caused accidents while driving in an Ambien-induced sleepwalking state. There are also reports of Ambien users binge eating in their sleep, leading to excessive weight gain.[] Read more Avandia, or rosiglitazone, is a popular anti-diabetic drug prescribed to help patients control their sugar levels. Millions of type II diabetes patients take Avandia to help control their blood-sugar levels, but its also linked to an increased risk of heart attacks. [] Read more Baycol is prescribed to help control excess cholesterol in the bloodstream that can lead to hardening of Continue reading >>

Invokamet, Invokana Lawsuit Investigation: Diabetes Amputation, Diabetic Ketoacidosis

Invokamet, Invokana Lawsuit Investigation: Diabetes Amputation, Diabetic Ketoacidosis

Were you or a loved one injured by Invokana side effects or Invokamet side effects? The U.S. Food and Drug Administration has warned that taking certain type-2 diabetes medications may increase patients’ risk of lower limb amputation and diabetic ketoacidosis. These diabetes side effects are associated with a class of drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors. SGLT2 inhibitor diabetes medications include: Invokana (canagliflozin) Invokamet (canagliflozin metformin) Invokamet XR (canagliflozin and metformin hydrochloride extended-release) If you or a loved one were diagnosed with diabetic ketoacidosis and/or had to undergo diabetic amputation of the toe, foot, knee or leg after taking one of the diabetes drugs listed above, you may have a legal claim. Fill out the form on this page now for a FREE case evaluation. The FDA has confirmed an increased risk of leg and foot amputations with the diabetes medicine canagliflozin, sold under the brand names Invokana, Invokamet, Invokamet XR. Studies show that people taking these medications are twice as likely to undergo lower limb amputation compared to patients taking a placebo, including diabetic amputation of the toe, foot, knee or leg. Diabetic amputations of the toe and middle of the foot were the most common; however, diabetic amputations involving the leg, both below and above the knee, also occurred. Some patients had more than one lower limb amputation, some involving both limbs, according to the FDA. The risk for Invokana amputation and Invokamet amputation may be higher for some people, including those who have peripheral vascular disease, neuropathy (nerve damage), or diabetic foot ulcers (sores), or who have a history of prior diabetes amputation. In a May 16, 2017 safety announcement, the FDA Continue reading >>

Type 2 Diabetes Drugs

Type 2 Diabetes Drugs

Type 2 Diabetes Drugs No one wants to believe that the medication they’re taking could make an ailment even worse. This is especially true when the medication is meant to help with something as potentially serious as type 2 diabetes and when making it worse could mean death. Below are some examples of drugs you’ll want to know about because of these very risks. Treating Type 2 Diabetes Diabetes is a condition wherein your body produces blood glucose levels far above what are needed. Type 2 diabetes is by far the most common form and is a result of the body being unable to use insulin correctly. This insulin resistance means that, over time, the pancreas can’t make sufficient levels for normal functioning. There are some ways to treat type 2 diabetes, and even more, medications have been invented to do so. In general, which one a patient will be described will depend on some other factors. The following prescription drugs may be popular, but they have also been the subject of lawsuits because of potential connections they have with serious side effects. Invokana Lawsuits Invokana is a diabetes medication taken orally that is designed to help control blood sugar levels. To do this, it assists with the kidneys cleaning the bloodstream of glucose. It may also lead to kidney failure, heart attacks, and ketoacidosis. That last condition occurs when a high amount of ketones (toxic acids that are the result of the body burning fat instead of glucose) are produced and allowed into the bloodstream. The result could be a diabetic coma and even death. Actos is known as an “insulin sensitizer.” By itself, it will not result in lower blood glucose. However, doctors still prescribe it because the drug is effective at reducing how much glucose is released by the liver. Unfort Continue reading >>

Diabetes Drug Gets Fda Warning Due To Amputation Risk

Diabetes Drug Gets Fda Warning Due To Amputation Risk

HealthDay Reporter WEDNESDAY, May 17, 2017 (HealthDay News) -- The type 2 diabetes prescription drug canagliflozin (brand names Invokana, Invokamet, Invokamet XR) appears to increase the risk of leg and foot amputations, the U.S. Food and Drug Administration says. The FDA is requiring the medications to carry new warnings about the risk. The required warnings on the drug's labeling include the most serious and prominent boxed warning. The agency's decision is based on data from two large clinical trials showing that leg and foot amputations occurred about twice as often in patients taking canagliflozin as among those taking a placebo. Amputations of the toe and middle of the foot were the most common, but leg amputations below and above the knee also occurred. Some patients had more than one amputation, some had amputations involving both limbs, according to the FDA. Type 2 diabetes occurs when the body becomes resistant to insulin. Insulin is a hormone that helps to usher sugar from foods into the body's cells. When this process doesn't work correctly, blood sugar levels rise. Left untreated, high blood sugar levels can cause a number of possible complications, including heart disease, kidney problems and amputations, according to the American Diabetes Association. Canagliflozin is meant to be used with diet and exercise to lower blood sugar in adults with type 2 diabetes. It belongs to a class of drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors. These drugs lower blood sugar levels by causing the kidneys to remove sugar from the body through the urine. It is available as a single-ingredient product under the brand name Invokana and also in combination with the diabetes medicine metformin under the brand name Invokamet. Patients taking canagliflozin shoul Continue reading >>

Why Do Diabetes Drugs Keep Getting More Expensive? | Keller Rohrback

Why Do Diabetes Drugs Keep Getting More Expensive? | Keller Rohrback

Why diabetes drugs keep getting more expensive Credit: Francis Ying, Julie Appleby, Stephanie Stapleton, National Public Radio The ever-increasing cost of diabetes drugs and products such as insulin, Glucagon, GlucaGen, glucose test strips, and Victoza means that many people with diabetes cannot afford the diabetes medicines and healthcare products they need to stay alive. Patients ration insulin, buy test strips on gray markets or simply forgo expensive treatments. The unaffordability of diabetes drugs and products is creating a health-care disaster in this country. Diabetes drug and product manufacturers are partly to blame for the unaffordability of diabetes care. But they are not acting alone. While manufacturers set a drugs price, known as the list price, another player in the prescription drug supply chain is to blame as well. cy benefit managers (PBMs) are supposed to manage formularies (lists of covered drugs and pricing tiers) for health plans and make sure prices are controlled. They also negotiate rebates with drug companies for buying drugs in bulk for their clients, which are insurers and self-insured employers, as well as union health plans. However, while PBMs claim theylowerdrug prices, they have used their role as gatekeepers in the pharmaceutical supply chain to extract larger and larger rebates for themselves and, in the process, they have driven drug pricesup. Manufacturers raise list prices to satisfy PBMs demands for rebates to secure their position on drug formularies. Under this pricing scheme, the more expensive a drug, the fatter the rebates and other fees the PBM can extract. And by raising the list price, the manufacturers ensure that their profit margins are not impacted negatively and may be greatly enhanced by the hikes in list price and Continue reading >>

Diabetes Medication Lawsuits

Diabetes Medication Lawsuits

A number of diabetes drugs have been linked in studies and lawsuits to serious drug side effects, including acute pancreatitis and pancreatic cancer. Some class action diabetes lawsuits have resulted in settlements with the plaintiffs. Other lawsuits are just getting underway. Whereas type 1 diabetics need to inject insulin several times a day to stay alive, type 2 diabetics are treated with a variety of glucose-lowering drugs, and combinations thereof. Type 2 diabetes occurs when the pancreas doesn't produce enough insulin to maintain a normal blood glucose level, or the body is unable to use the insulin that is produced. Diabetes, a lifelong condition, causes a person's blood sugar level to become too high. Four main risk factors for developing type 2 diabetes are genetics, age, weight and ethnicity. Almost 26 million Americans have diabetes, and up to 95 percent of these cases are type 2 diabetes. There are several classes of diabetes drugs that work in different ways to lower blood sugar (glucose). Sulfonylureas have been used to treat diabetes since the 1950s while the first drug in a new class of medications called DPP-4 inhibitors was approved by the FDA in 2006. Sitagliptin was the first DPP-4 Inhibitors approved, followed by a combined product of sitagliptin and glucophage and saxagliptin in 2007. A group of dugs known as incretin mimetics includes Byetta, Bydureon, Victoza, Januvia and other medications. Sulfonylureas Biguanides Meglitinides Thiazolidinediones DPP-4 inhibitors (gliptins, or dipeptidyl peptidase-4) SGLT2 Inhibitors (sodium-glucose cotransporter-2 ) Alpha-glucosidase inhibitors Bile Acid Sequestrant For more information visit the American Diabetes Association. Actos (exenatide) Associated risks: bladder cancer, heart failure. Avandia (rosiglitaz Continue reading >>

More in diabetes